Added to YB: 2024-07-19
Pitch date: 2024-07-12
CERT [bullish]
Certara, Inc.
-43.7%
current return
Author Info
No bio for this author
Company Info
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access.
Market Cap
$1.3B
Pitch Price
$15.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
13.14
P/E
123.15
EV/Sales
3.52
Sector
Health Care Technology
Category
growth
TimesSquare U.S. Small Cap Growth Strategy Added On: Certara, Inc.
CERT: Bio simulation software/services for drug discovery. Q1 rev beat, but bookings miss led to -22% selloff. Added on weakness due to improving biotech funding & clinical trial starts. Strong position in growing market with potential upside as sector recovers.
Read full article (1 min)